Bulletin Contents
Search
Home Page
 
Avricore Health Inc. 
Listed Company 

NUVA PHARMACEUTICALS INC. ("NPH")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: April 8, 2014
TSX Venture Tier 2 Company

TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced February 28, 2014:

Number of Shares: 3,750,000 shares

Purchase Price: $0.10 per share

Warrants: 2,000,000 share purchase warrants to purchase 2,000,000 shares

Warrant Exercise Price: $0.13 for a two year period

Number of Placees: 28 placees

Insider / Pro Group Participation:

Insider=Y /
Name ProGroup=P # of Shares

Aggregate Pro Group Involvement P 100,000
[1 placee]


Finder's Fee: 180,000 warrants is payable to Jit Mundie
$6,000 plus 60,000 warrants is payable to Hazma Thindal Capital Corporation (Kam Thindal and Essam Hazma).
$6,000 plus 60,000 warrants is payable to Jordan Capital Markets Inc.

(160,000 warrants expire 2 years after closing and 140,000 warrants expire one year after closing of the private placement. 160,000 warrants will be issued at $0.13 per share and 140,000 warrants will be issued at $0.30 per share)

Pursuant to Corporate Finance Policy 4.1, Section 1.11(d), the Company must issue a news release announcing the closing of the private placement and setting out the expiry dates of the hold period(s). The Company must also issue a news release if the private placement does not close promptly. Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.
________________________________________